These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


201 related items for PubMed ID: 28460464

  • 1. PPARγ activation by troglitazone enhances human lung cancer cells to TRAIL-induced apoptosis via autophagy flux.
    Nazim UM, Moon JH, Lee YJ, Seol JW, Park SY.
    Oncotarget; 2017 Apr 18; 8(16):26819-26831. PubMed ID: 28460464
    [Abstract] [Full Text] [Related]

  • 2. Activation of autophagy flux by metformin downregulates cellular FLICE-like inhibitory protein and enhances TRAIL- induced apoptosis.
    Nazim UM, Moon JH, Lee JH, Lee YJ, Seol JW, Eo SK, Lee JH, Park SY.
    Oncotarget; 2016 Apr 26; 7(17):23468-81. PubMed ID: 26992204
    [Abstract] [Full Text] [Related]

  • 3. Glipizide sensitizes lung cancer cells to TRAIL-induced apoptosis via Akt/mTOR/autophagy pathways.
    Nazim UM, Moon JH, Lee YJ, Seol JW, Kim YJ, Park SY.
    Oncotarget; 2017 Nov 21; 8(59):100021-100033. PubMed ID: 29245957
    [Abstract] [Full Text] [Related]

  • 4. Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-Troglitazone-induced Apoptosis in Prostate Cancer Cells Involve AMP-activated Protein Kinase.
    Santha S, Viswakarma N, Das S, Rana A, Rana B.
    J Biol Chem; 2015 Sep 04; 290(36):21865-75. PubMed ID: 26198640
    [Abstract] [Full Text] [Related]

  • 5. Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling.
    Yan J, Yang H, Wang G, Sun L, Zhou Y, Guo Y, Xi Z, Jiang X.
    Autophagy; 2010 Jan 04; 6(1):67-73. PubMed ID: 19923924
    [Abstract] [Full Text] [Related]

  • 6. The PPARγ agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells.
    Yan S, Yang X, Chen T, Xi Z, Jiang X.
    Cancer Gene Ther; 2014 May 04; 21(5):188-93. PubMed ID: 24853624
    [Abstract] [Full Text] [Related]

  • 7. Troglitazone sensitizes tumor cells to TRAIL-induced apoptosis via down-regulation of FLIP and Survivin.
    Schultze K, Böck B, Eckert A, Oevermann L, Ramacher D, Wiestler O, Roth W.
    Apoptosis; 2006 Sep 04; 11(9):1503-12. PubMed ID: 16820965
    [Abstract] [Full Text] [Related]

  • 8. Ophiopogonin B sensitizes TRAIL-induced apoptosis through activation of autophagy flux and downregulates cellular FLICE-like inhibitory protein.
    Nazim UM, Jeong JK, Park SY.
    Oncotarget; 2018 Jan 09; 9(3):4161-4172. PubMed ID: 29423112
    [Abstract] [Full Text] [Related]

  • 9. Caspase-mediated cleavage of beta-catenin precedes drug-induced apoptosis in resistant cancer cells.
    Senthivinayagam S, Mishra P, Paramasivam SK, Yallapragada S, Chatterjee M, Wong L, Rana A, Rana B.
    J Biol Chem; 2009 May 15; 284(20):13577-13588. PubMed ID: 19289465
    [Abstract] [Full Text] [Related]

  • 10. Insights on distinct pathways of thiazolidinediones (PPARgamma ligand)-promoted apoptosis in TRAIL-sensitive or -resistant malignant urothelial cells.
    Plissonnier ML, Fauconnet S, Bittard H, Lascombe I.
    Int J Cancer; 2010 Oct 15; 127(8):1769-84. PubMed ID: 20099277
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of the autophagy flux by gingerol enhances TRAIL-induced tumor cell death.
    Nazim UM, Jeong JK, Seol JW, Hur J, Eo SK, Lee JH, Park SY.
    Oncol Rep; 2015 May 15; 33(5):2331-6. PubMed ID: 25813697
    [Abstract] [Full Text] [Related]

  • 12. [The anti-diabetic drug troglitazone sensitizes colon cancer cells to TRAIL-induced apoptosis by down-regulating FLIP].
    Roth W, Grund K, Wiestler OD, Schirmacher P.
    Verh Dtsch Ges Pathol; 2007 May 15; 91():294-301. PubMed ID: 18314627
    [Abstract] [Full Text] [Related]

  • 13. Combined treatment with TRAIL and PPARγ ligands overcomes chemoresistance of ovarian cancer cell lines.
    Bräutigam K, Biernath-Wüpping J, Bauerschlag DO, von Kaisenberg CS, Jonat W, Maass N, Arnold N, Meinhold-Heerlein I.
    J Cancer Res Clin Oncol; 2011 May 15; 137(5):875-86. PubMed ID: 20878528
    [Abstract] [Full Text] [Related]

  • 14. Troglitazone suppresses c-Myc levels in human prostate cancer cells via a PPARγ-independent mechanism.
    Akinyeke TO, Stewart LV.
    Cancer Biol Ther; 2011 Jun 15; 11(12):1046-58. PubMed ID: 21525782
    [Abstract] [Full Text] [Related]

  • 15. Troglitazone induced apoptosis via PPARγ activated POX-induced ROS formation in HT29 cells.
    Wang J, Lv X, Shi J, Hu X, DU Y.
    Biomed Environ Sci; 2011 Aug 15; 24(4):391-9. PubMed ID: 22108328
    [Abstract] [Full Text] [Related]

  • 16. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms.
    Pandhare J, Cooper SK, Phang JM.
    J Biol Chem; 2006 Jan 27; 281(4):2044-52. PubMed ID: 16303758
    [Abstract] [Full Text] [Related]

  • 17. Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.
    Ban JO, Oh JH, Son SM, Won D, Song HS, Han SB, Moon DC, Kang KW, Song MJ, Hong JT.
    Cancer Biol Ther; 2011 Aug 15; 12(4):288-96. PubMed ID: 21613824
    [Abstract] [Full Text] [Related]

  • 18. Peroxisome proliferator-activated receptor γ ligand troglitazone and TRAIL synergistically induce apoptosis.
    Koyama M, Sowa Y, Horinaka M, Goda AE, Fujiwara J, Sakai T.
    Oncol Rep; 2014 Feb 15; 31(2):947-54. PubMed ID: 24276615
    [Abstract] [Full Text] [Related]

  • 19. A peroxisome proliferator-activated receptor-gamma agonist, troglitazone, facilitates caspase-8 and -9 activities by increasing the enzymatic activity of protein-tyrosine phosphatase-1B on human glioma cells.
    Akasaki Y, Liu G, Matundan HH, Ng H, Yuan X, Zeng Z, Black KL, Yu JS.
    J Biol Chem; 2006 Mar 10; 281(10):6165-74. PubMed ID: 16319070
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of ERK activity enhances the cytotoxic effect of peroxisome proliferator-activated receptor γ (PPARγ) agonists in HeLa cells.
    Chang HK, Kim DS, Chae JJ, Kim M, Myong JP, Lee KH, Lee MW, Park TC.
    Biochem Biophys Res Commun; 2017 Jan 22; 482(4):843-848. PubMed ID: 27888104
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.